Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer.

Trial Profile

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Letrozole (Primary)
  • Indications Advanced breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 19 Apr 2012 Actual patient number is 31 as reported by ClinicalTrials.gov.
    • 29 Sep 2009 Planned number of patients (30) added as reported by ClinicalTrials.gov.
    • 05 Jul 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top